Navigation Links
Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27
Date:4/9/2012

FARMINGTON, Conn., April 9, 2012 /PRNewswire-iReach/ -- Global Information, Inc. is excited to announce remaining available registration for 3 significant Drug Discovery and Healthcare conferences scheduled for Boston, MA in the Spring of 2012.

CHI and Bio-IT World's 12th Annual Structure-Based Drug Design Conference

June 6 - 8, 2012: Structure-based drug design took nearly two decades to arrive at its current mainstream position in medicinal chemistry, and the CHI and Bio-IT World's 12th Annual Structure-Based Drug Design Conference in Cambridge, MA will host an accomplished faculty of experts to focus on recent advancements in this ever evolving, dynamic field. With the crisis facing the pharmaceutical industry in the translation of early stage drug discovery results, a different set of tools concerned with algorithms and methods for developing best-in-class drugs will need to be refined. Join hundreds of colleagues at this excellent once-a-year opportunity to network and share experiences and intelligence.

Save $200 by registering before April 27. Additional information and Early Bird discounted rates at http://www.giiconference.com/chi214654-2012/

Next-Gen Kinase Inhibitors

June 4 - 6, 2012: Explore the exciting question of what lies ahead for the rapidly maturing kinase inhibitors field when pioneers from across the world gather to at the Next-Gen Kinase Inhibitors Conference in Cambridge, MA this June. What is around the corner for the pharmaceutical industry and what new avenues lie ahead for new technologies and methods as novel targets and therapeutic approaches are explored? What ground-breaking kinase indications are being discovered and what other
'/>"/>

SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boston Scientific Launches Innovative Device Used to Prevent Stone Migration in Urologic Procedures
2. Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012
3. Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston on March 7, 2012
5. Boston Scientific Announces First Implants of TELIGEN® Implantable Defibrillator in China
6. Boston Scientific Receives Industrys First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
7. Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
8. Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
9. Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
10. Boston IVF Pioneers Worlds First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests
11. Boston Scientific Announces Favorable Ruling in Patent Infringement Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... with its OmniPod ® Insulin Management System, today ... appointed to Insulet,s Board of Directors. Dr. ... experience to the Insulet Board. She currently serves as ... Diabetes Center, the world,s largest diabetes research center, diabetes ...
(Date:7/28/2015)... 2015  Express Scripts Holding Company (Nasdaq: ESRX ... Express Scripts stockholders of $600.1 million, or $0.88 per ... in Table 4, were $1.44 for the second quarter. ... companies across healthcare are validating the need for size ... Officer. "But, what matters most is how that size ...
(Date:7/28/2015)... MENLO PARK, Calif. , July 28, 2015 ... global medical device company that is providing innovative ... today announced the publication of the SENZA-RCT results ... , the official Journal of the American Society of ... was a ground-breaking study that was the first ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2
... program is critical, CHICAGO, March 29 ... successfully in medical centers without,on-site cardiac surgical back-up, ... quality. These are the findings of the,largest clinical ... on-site,cardiac surgery to PCI programs that transfer patients ...
... Are Overweight and Do ... Device Applies Electrical Stimulation to Stomach as Person ... Hospital/Weill,Cornell Medical Center is recruiting patients for a national ... help,those with type-2 diabetes who are overweight and do ...
Cached Medicine Technology:Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 2Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 3Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery 4New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients 2
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... for inmates who continued methadone maintenance treatment (MMT) during incarceration versus those subjected ... relapse to opiate use (1) and more likely to require hospitalization or emergency ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part of Atlantic Health System, ... first five hospitals in the nation, to implant the newly approved CoreValve® Evolut® R ... all are in good condition. , The CoreValve® Evolut® R System was approved by ...
(Date:7/28/2015)... ... 28, 2015 , ... Healthline , a provider of intelligent health information ... consumers’ perspectives on digital health . The survey, which was conducted among 3,679 ... digital health, level of trust in the security of digital health tools, impact of ...
(Date:7/28/2015)... ... ... Dr. Aziz Ahmad recently gave a talk on the current treatments of ... Tuesday, June 23, at the Gulf Coast Regional Medical Center Large HR Classroom, 449 ... surgery and has more than 35 years of experience in the surgical specialty. He ...
(Date:7/28/2015)... ... ... According to Kxan on June 24th a previously FDA approved blood ... study involving isradipine has garnered national attention and is making drug and alcohol rehabilitation ... alcohol addictions. The study was conducted by the University of Texas. Human trials may ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3
... Make Harmful Choices in Efforts to Contain Costs , ... San Mateo, ... make more difficult economic choices than ever before. A new survey ... nationwide are concerned patients are being forced to make cutbacks on medications ...
... in northern Illinois to use a new, cutting ... improve patient care and outcomes.WOBURN, Mass. and VEDBAEK, ... Anthony Medical Center in Rockford, Illinois has implemented ... 1 to 3 days earlier than conventional methods ...
... today,announced the initiation of a Phase IIa clinical trial ... being developed for,the treatment of type 2 diabetes. S-EH ... a key signaling molecule implicated in diabetes,hypertension and inflammatory ... II clinical trial program breaks new ground in two ...
... shows signs of stabilization; December 2008 to January 2009 ... CINCINNATI, Feb. 10 /PRNewswire-FirstCall/ -- LCA-Vision Inc. ... laser vision correction services under the Lasik Plus (R) ... three and 12 months ended December 31, 2008. Fourth ...
... end to insurer scheme that shifts medical ... Feb. 10 The American Medical Association ... the Medical Society of New Jersey, joined ... lawsuits against Aetna Health, Inc. and CIGNA ...
... Veterans Relief Fund ( http://www.disabledveteransrelieffund.org ) today announced its .99 CENT ... month to help disabled veterans and their families--and every person who ... raffle for a grand prize valued at $25,000. , ... ...
Cached Medicine News:Health News:Doctors Fear Patients Not Filling Prescriptions 2Health News:Doctors Fear Patients Not Filling Prescriptions 3Health News:OSF Saint Anthony Medical Center Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:OSF Saint Anthony Medical Center Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 2Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 3Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 2Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 3Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 4Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 5Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 6Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 7Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 8Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 9Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 10Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 11Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 12Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 13Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 14Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 15Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 16Health News:AMA Announces Physician Class-Actions Against Aetna and CIGNA 2Health News:With So Many Charities Struggling In This Economy, Disabled Veterans Relief Fund Is Thriving With a .99 Cent Fundraiser Program 2Health News:With So Many Charities Struggling In This Economy, Disabled Veterans Relief Fund Is Thriving With a .99 Cent Fundraiser Program 3
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products: